Bando Chemical Industries, Ltd. (TYO:5195)
Japan · Delayed Price · Currency is JPY 2,423.00
+3.00 (0.12%)
Jul 31, 2026, 3:30 PM JST
Bando Chemical Industries Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 119,257 | 115,593 | 108,278 | 103,608 | 93,744 | |
Revenue Growth | 3.17% | 6.76% | 4.51% | 10.52% | 15.21% |
Cost of Revenue | 83,629 | 82,805 | 77,246 | 74,186 | 66,081 |
Gross Profit | 35,628 | 32,788 | 31,032 | 29,422 | 27,663 |
Selling, General & Admin | 26,076 | 25,044 | 23,447 | 22,687 | 21,782 |
Other Operating Expenses | -1,426 | 120 | -113 | -127 | -110 |
Operating Expenses | 24,650 | 25,164 | 23,334 | 22,560 | 21,672 |
Operating Income | 10,978 | 7,624 | 7,698 | 6,862 | 5,991 |
Interest Expense | -114 | -94 | -89 | -84 | -120 |
Interest & Investment Income | 503 | 556 | 422 | 327 | 291 |
Earnings From Equity Investments | 1,223 | 1,629 | 1,468 | 1,448 | 1,025 |
Currency Exchange Gain (Loss) | 448 | -285 | 827 | 305 | 550 |
Other Non Operating Income (Expenses) | -140 | 274 | -218 | -227 | 61 |
EBT Excluding Unusual Items | 12,898 | 9,704 | 10,108 | 8,631 | 7,798 |
Merger & Restructuring Charges | - | -1,117 | - | - | - |
Gain (Loss) on Sale of Assets | -11 | -25 | -6 | -76 | -58 |
Asset Writedown | -242 | -5,091 | -1,427 | -14 | -4,327 |
Pretax Income | 12,645 | 3,471 | 8,675 | 8,541 | 3,413 |
Income Tax Expense | 2,055 | 1,931 | 2,458 | 2,780 | 2,197 |
Earnings From Continuing Operations | 10,590 | 1,540 | 6,217 | 5,761 | 1,216 |
Minority Interest in Earnings | -22 | -44 | -37 | -39 | -5 |
Net Income | 10,568 | 1,496 | 6,180 | 5,722 | 1,211 |
Net Income to Common | 10,568 | 1,496 | 6,180 | 5,722 | 1,211 |
Net Income Growth | 606.42% | -75.79% | 8.00% | 372.50% | -69.29% |
Shares Outstanding (Basic) | 41 | 42 | 43 | 44 | 45 |
Shares Outstanding (Diluted) | 41 | 42 | 43 | 44 | 45 |
Shares Change | -2.76% | -2.27% | -1.53% | -2.16% | -1.22% |
EPS (Basic) | 256.48 | 35.31 | 142.55 | 129.96 | 26.91 |
EPS (Diluted) | 256.48 | 35.31 | 142.55 | 129.96 | 26.91 |
EPS Growth | 626.44% | -75.23% | 9.68% | 382.92% | -68.91% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 10,861 | 6,497 | 9,940 | 4,188 | 6,124 |
Free Cash Flow Per Share | 263.59 | 153.33 | 229.28 | 95.12 | 136.09 |
Dividend Per Share | 100.000 | 76.000 | 72.000 | 52.000 | 40.000 |
Dividend Growth | 31.58% | 5.56% | 38.46% | 30.00% | 53.85% |
Gross Margin | 29.88% | 28.37% | 28.66% | 28.40% | 29.51% |
Operating Margin | 9.21% | 6.60% | 7.11% | 6.62% | 6.39% |
Profit Margin | 8.86% | 1.29% | 5.71% | 5.52% | 1.29% |
Free Cash Flow Margin | 9.11% | 5.62% | 9.18% | 4.04% | 6.53% |
EBITDA | 16,428 | 13,442 | 13,557 | 12,756 | 11,883 |
EBITDA Margin | 13.78% | 11.63% | 12.52% | 12.31% | 12.68% |
D&A For EBITDA | 5,450 | 5,818 | 5,859 | 5,894 | 5,892 |
EBIT | 10,978 | 7,624 | 7,698 | 6,862 | 5,991 |
EBIT Margin | 9.21% | 6.60% | 7.11% | 6.62% | 6.39% |
Effective Tax Rate | 16.25% | 55.63% | 28.33% | 32.55% | 64.37% |